Drug recall · June 6, 2018
POSEIDON Xtreme PLATINUM 4500 recall
Why: Marketed Without An Approved NDA/ANDA: FDA analysis found products to contain undeclared sildenafil and tadalafil. The presence of sildenafil and tadalafil makes these products an unapproved drug for which safety and efficacy have not been established and, therefore, subject to recall.
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
POSEIDON Xtreme PLATINUM 4500,1000mg, packaged in single packs sold in 24-count boxes, Distributed by: Poseidon Distribution Atlanta, GA, UPC 638632428857
- Lots / codes
Lot #: 201117BL, Exp. 01/2020
- Quantity
- Unknown
- Company
- Shoreside Enterprises Inc., Tampa, FL
- Distribution
- Nationwide.
- Initiated
- May 17, 2018 · Voluntary: Firm initiated
- Classified
- June 18, 2018
- Reported
- June 6, 2018
- Ended
- June 10, 2020
- How notified
- Press Release
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.